Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2026-02-01 @ 2:38 AM
Study NCT ID:
NCT06290193
Status:
RECRUITING
Last Update Posted:
2025-05-22
First Post:
2024-02-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Ovarian Cancer | View |
| None | Fallopian Tube Carcinoma | View |
| None | Ovarian Carcinoma | View |
| None | Peritoneal Carcinoma | View |
| None | Ovarian Cancer Stage IIIC | View |
| None | Fallopian Tube Cancer Stage IIIC | View |
| None | Ovarian Cancer Stage IV | View |
| None | Fallopian Tube Cancer Stage IV | View |
| None | Fallopian Tube Cancer | View |
| None | Peritoneal Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | ovarian cancer | View |
| None | ovarian carcinoma | View |
| None | ovarian cancer stage IIIC | View |
| None | ovarian cancer stage IV | View |
| None | fallopian tube cancer | View |
| None | fallopian tube carcinoma | View |
| None | fallopian tube cancer stage IIIC | View |
| None | fallopian tube cancer stage IV | View |
| None | peritoneal cancer | View |
| None | peritoneal carcinoma | View |
| None | Acute Normovolemic Hemodilution | View |
| None | Memorial Sloan Kettering Cancer Center | View |
| None | 23-392 | View |